fireflyneuro.com (AIFF) - Narxning prognoz qilingan daromadga nisbati
FDA sertifikatsiyasi uchun yuqori xarajatlar va AI platformalarining patent himoyasi Firefly Neuroscience, Inc (AIFF) kompaniyasining o'sish dinamikasiga ta'sir ko'rsatmoqda. Forward P/S koeffitsiyenti kelajakdagi daromadlar nisbatida joriy bozor kapitalizatsiyasini aks ettiradi va ushbu ko'rsatkich 7.40 miqdorida qat'iy belgilangan. Aniqlik darajasi yuqori bo'lgan EEG dekodlash tufayli nevrologlar orasida brend obro'si ortib bormoqda, demensiyani diagnostika qiluvchi noyob dasturiy ta'minot esa kompaniyaga ushbu tor doiradagi bozorda barqaror narx belgilash imkoniyatini beradi.
Firefly Neuro (AIFF) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi ko'rsatkichlari:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- kompaniyaning jami qarzi va likvidligi ko'rsatkichlari:
Qarzning xususiy kapitalga nisbati Firefly Neuroscience, Inc|AIFF - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati Firefly Neuroscience, Inc|AIFF - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans kapitallashuviga nisbati AIFF|AIFF - Uzoq muddatli qarz hajmi|Kompaniyaning qisqa muddatli qarzlari Firefly Neuroscience|Tezkor likvidlik koeffitsiyenti fireflyneuro.com
- moliyaviy natijalar va qiymat multiplikatorlari tafsilotlari:
AIFF - Sof moliyaviy natija|Prognoz qilingan kelajakdagi foyda Firefly Neuroscience, Inc|AIFF - Kapitalizatsiyaning foydaga nisbati|Kelajakdagi narxning foydaga nisbati Firefly Neuroscience Inc|AIFF - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|EV/EBITDA multiplikatori AIFF|AIFF - Eskirish chegirilmasdan oldingi operatsion foyda|Bir aksiya uchun sof foyda (EPS TTM) Firefly Neuroscience|AIFF - So'nggi o'n ikki oy davomida bitta aksiya uchun sof foyda|So'nggi 12 oy davomida bir aksiya uchun sof foydaning yillik o'sishi fireflyneuro.com|AIFF - Joriy yilda bir aksiya uchun foyda ortishi|Keyingi yil uchun foyda o'sishi prognozi Firefly Neuroscience, Inc
- tushum va sotuvlar tafsilotlari:
Kompaniyaning dastlabki tahlili:AIFF (Firefly Neuroscience)
Fundamental yetakchilarni aniqlash uchun tahlilchi bozor kapitalizatsiyasining kutilayotgan yillik daromadga nisbatini baholaydi, bu esa kelajakdagi o'sish uchun to'langan premiumni belgilaydi. Bashorat qilingan P/S ko'rsatkichi Firefly Neuroscience, Inc (AIFF) tomonidan AI asosidagi miya faoliyati diagnostikasining tijoratlashtirilishiga nisbatan bozor kutganlarini aks ettiradi, bu esa investorlarga aksiya narxini obyektiv neyrobiologik ma'lumotlarni klinik amaliyotga integratsiya qilish imkoniyati bilan muvofiqlashtirishga yordam beradi.
Raqobatdosh kompaniyalar tahlili
Biogen - Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx NBIX|RGC - Narxning prognoz qilingan daromadga nisbati|AXSM (Axsome Corp) - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|ACAD: Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati xenon-pharma.com (XENE)|Forvard narx/daromad multiplikatori VKTX|Forvard P/S multiplikatori Supernus Pharmaceuticals, Inc.|Narxning prognoz qilingan daromadga nisbati Catalyst Pharmaceuticals Inc (CPRX)|DNLI (Denali Corp) - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Harmony Biosciences HRMY|biohavenpharma.com (BHVN) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|AMLX - Narxning prognoz qilingan daromadga nisbati|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Trevi Therapeutics Inc TRVI|PRAX: Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori Anavex Life Sciences Corp|CBLL (CeriBell, Inc.) - Forvard P/S multiplikatori|Prothena Corporation (PRTA) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard P/S multiplikatori ALEC|ANNX - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Narxning prognoz qilingan daromadga nisbati Omeros OMER|NGNE: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|AC Immune - Forvard P/S multiplikatori|voyagertherapeutics.com (VYGR) - Forvard narx/daromad multiplikatori|NMRA: Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Scilex Holding (SCLX)|Forvard narx/daromad multiplikatori TVGN|ACOG: Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori CGTX|Kapitalizatsiyaning kutilayotgan sotuvga nisbati inhibikase.com|Narxning prognoz qilingan daromadga nisbati Cassava Sciences SAVA|ASRT: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Coya - Forvard P/S multiplikatori|Vistagen Therapeutics (VTGN) - Forvard narx/daromad multiplikatori|OVID: Forvard P/S multiplikatori|acumenpharm.com (ABOS) - Forvard P/S multiplikatori|CRVO (CervoMed) - Forvard P/S multiplikatori|Alterity Therapeutics Ltd (ATHE) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard P/S multiplikatori CLNN|PEPG: Kelajakdagi narxning daromadga nisbati|Forvard P/S multiplikatori JUNS (Jupiter Neurosciences Inc)|RLMD (relmada.com) - Kelajakdagi narxning daromadga nisbati|ANVS - Narxning prognoz qilingan daromadga nisbati|GRCE (Grace Therapeutics, Inc.) - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|KLTO: Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati NeuroSense Therapeutics Ltd. (NRSN)|Forvard narx/daromad multiplikatori RVPH|Forvard P/S multiplikatori MetaVia, Inc.|Narxning prognoz qilingan daromadga nisbati NeurAxis (NRXS)|HSDT (heliusmedical.com) - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Passage Bio PASG|Neuphoria Therapeutics, Inc. (NEUP) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Minerva Neurosciences - Forvard P/S multiplikatori|Kelajakdagi narxning daromadga nisbati ATHA|ADXN: Forvard P/S multiplikatori|ALZN - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati Cyclerion Therapeutics Inc.|PTIX: Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori KTTA|CRGT - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Forvard P/S multiplikatori ATXI (Avenue Therapeutics, Inc.)|BCLI (Brainstorm Cell Therapeutics Inc.) - Kelajakdagi narxning daromadga nisbati|CARA - Narxning prognoz qilingan daromadga nisbati|CHRO: Narxning prognoz qilingan daromadga nisbati|ELYM (eliemtx.com) - Forvard narx/daromad multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Intra-Cellular Therapies, Inc. (ITCI)|Forvard narx/daromad multiplikatori LBPH|MRNS: Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati NKGen (NKGN)|NeuroBo Pharma - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Forvard P/S multiplikatori SAGE (Sage Therapeutics, Inc.)|synaptogen.com (SNPX) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|TRVN: Forvard narx/daromad multiplikatori|VIGL - Forvard P/S multiplikatori|Anew Medical (WENA) - Narxning prognoz qilingan daromadga nisbati|Cerevel Corp - Sotuvga nisbatan forvard narx
